A national screening policy for sickle cell disease and thalassaemia major for the United Kingdom - Questions are left after two evidence based reports

被引：12

作者：

Streetly, A ^{[1
]}

机构：

[1] Kings Coll London, Dept Publ Hlth Sci, London SE1 3QD, England

来源：

BRITISH MEDICAL JOURNAL | 2000年 / 320卷 / 7246期

关键词：

D O I：

10.1136/bmj.320.7246.1353

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1353 / 1354

页数：2

共 9 条

[1]

[Anonymous], 2000, HLTH TECHNOL ASSESS

[2]

GRANDA H, 1991, LANCET, V337, P152

[3]

*HLTH DEP UK, 1998, NAT SCREEN COMM 1 RE

[4] Informed choice in genetic screening for thalassaemia during pregnancy: audit from a national confidential inquiry [J].

Modell, B ;

Harris, R ;

Lane, B ;

Khan, M ;

Darlison, M ;

Petrou, M ;

Old, J ;

Layton, M ;

Varnavides, L .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7231) :337-341

[5]

Modell B, 1997, BRIT MED J, V315, P779, DOI 10.1136/bmj.315.7111.779

[6]

*NHS EX, 1999, STAND MED ADV COMM W

[7] SICKLE-CELL DISEASE - THE CASE FOR COORDINATED INFORMATION [J].

STREETLY, A ;

DICK, M ;

LAYTON, M .

BRITISH MEDICAL JOURNAL, 1993, 306 (6891) :1491-1492

[8]

STREETLY A, 1997, SICKLE CELL DISORDER

[9]

ZEUNER D, 1999, HLTH TECHNOL ASSESS, V3

← 1 →